Metabolic disorders. Metabolic disorder, unspecified
Conditions
Interventions
Intervention 1: Control: prescription placebo. Intervention 2: intervention: prescription l carnitine.
Placebo
Treatment - Drugs
Control: prescription placebo
intervention: prescription l carnitine
Sponsors
Research Vice Chancellar of Ahwaz University of Medical Sciense
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: exclusion criteria: any acute illness of up to one month prior to the study or during the study, is leading to hospitalization?2 patients who have known allergies to L-carnitine? cirrhosis of the liver or AST, LT> 45? Patients who are taking vitamin E or C during the study or any known antioxidant. (From 2 weeks before and 2 weeks after starting the drug L-carnitine)? previous failure EF <35%. Inclusion criteria: all over 18 years and were undergoing hemodialysis three times a week for at least three months past the initiation of dialysis .
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oxidized LDL. Timepoint: Before the start of the study and 12 weeks later we measured serum levels of LDL. Method of measurement: Instrumental method based on mg / dl. | — |
Secondary
| Measure | Time frame |
|---|---|
| MDA. Timepoint: Before the start of the study and 12 weeks later we measured serum levels of MDA. Method of measurement: Instrumental method based on mg /dl. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShokoh shayanpoor
Ahwaz University of Medical Sciences
Outcome results
None listed